chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Inflammation
Clinical narrative: she had trouble with it. SHe mentioned inflammation; This is a spontaneous report from a contactable consumer. A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE: Solution for injection; Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date of Mar2021 as dose number unknown, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. Caller said she had the Pfizer COVID-19 vaccine last Mar2021 and she had trouble with it. She mentioned inflammation. She said she has already made a report about it with Pfizer. Caller has seen on the news about people getting the third dose of the Pfizer COVID-19 vaccine. Caller is hesitant about getting a third dose because of her unpleasant experience. She wanted to know what would happen to her if she did not take the third dose. Caller ranted that it was bad for Pfizer not knowing information about regulations of COVID-19 vaccines in other countries. She and her friend had taken the Pfizer COVID-19 vaccines in one country and her friend's vaccination card was not recognized in other country. She said that she is sure that they are not the only ones who have problems in getting their vaccine recognized in other countries. She mentioned that her friend has spent thousands of dollars to fly to get vaccinated and when she returned to it was not accepted. She said that Pfizer should sort this problem and not just be about politics. She is not happy with the situation. The outcome of the event inflammation was unknown.  The lot number for the vaccine, (BNT162B2), was not provided and will be requested during follow-up.
Age: 60.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Tinnitus
Clinical narrative: continuous ringing in his ear
Age: 68.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Electromyogram, Guillain-Barre syndrome, Magnetic resonance imaging, Muscular weakness, Musculoskeletal disorder
Clinical narrative: GUILLIAN-BARRE SYNDROME DIAGNOSIS SYMPTOMS- SELF LIMITING AUTOIMMUNE, DISFUNCTION IN MOTOR SKILLS AND SENSORY DISFUNCTION, NUMBNESS IN HANDS AND LEGS, DIZZNESS AND GENERAL WEAKNESS  TREATMENT- PLAMSA THERAPIES, PHYSICAL THERAPY AND VARIOUS MEDCICATIONS
Age: 68.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Plasmapheresis
Clinical narrative: GUILLIAN-BARRE SYNDROME DIAGNOSIS SYMPTOMS- SELF LIMITING AUTOIMMUNE, DISFUNCTION IN MOTOR SKILLS AND SENSORY DISFUNCTION, NUMBNESS IN HANDS AND LEGS, DIZZNESS AND GENERAL WEAKNESS  TREATMENT- PLAMSA THERAPIES, PHYSICAL THERAPY AND VARIOUS MEDCICATIONS
Age: 68.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Asthenia, Autoimmune disorder, Dizziness, Fine motor skill dysfunction, Guillain-Barre syndrome
Clinical narrative: GUILLIAN-BARRE SYNDROME DIAGNOSIS SYMPTOMS- SELF LIMITING AUTOIMMUNE, DISFUNCTION IN MOTOR SKILLS AND SENSORY DISFUNCTION, NUMBNESS IN HANDS AND LEGS, DIZZNESS AND GENERAL WEAKNESS  TREATMENT- PLAMSA THERAPIES, PHYSICAL THERAPY AND VARIOUS MEDCICATIONS
Age: 68.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Hypoaesthesia, Sensory integrative dysfunction
Clinical narrative: GUILLIAN-BARRE SYNDROME DIAGNOSIS SYMPTOMS- SELF LIMITING AUTOIMMUNE, DISFUNCTION IN MOTOR SKILLS AND SENSORY DISFUNCTION, NUMBNESS IN HANDS AND LEGS, DIZZNESS AND GENERAL WEAKNESS  TREATMENT- PLAMSA THERAPIES, PHYSICAL THERAPY AND VARIOUS MEDCICATIONS
Age: 48.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dyspnoea, Rash
Clinical narrative: Full body rash, severe itching, joint and muscle pain, body aches, fever, blistering on my toes, very sore peeling and bleeding on my ears, fatigue, fever blister on my tongue
Age: 48.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Blister, Fatigue, Myalgia, Oral herpes
Clinical narrative: Full body rash, severe itching, joint and muscle pain, body aches, fever, blistering on my toes, very sore peeling and bleeding on my ears, fatigue, fever blister on my tongue
Age: 48.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pain, Pruritus, Pyrexia, Rash, Skin exfoliation
Clinical narrative: Full body rash, severe itching, joint and muscle pain, body aches, fever, blistering on my toes, very sore peeling and bleeding on my ears, fatigue, fever blister on my tongue
Age: 48.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Skin haemorrhage
Clinical narrative: Full body rash, severe itching, joint and muscle pain, body aches, fever, blistering on my toes, very sore peeling and bleeding on my ears, fatigue, fever blister on my tongue
Age: 72.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Aplasia, Aspiration bone marrow abnormal, Biopsy bone marrow abnormal, Haemoglobin decreased, Pancytopenia
Clinical narrative: 72-year-old female with a known medical history of DM, GERD, hypercholesterolemia, panic disorder, and daily ETOH use (2 large glasses of whiskey every night, last drink 8/21) presented 8/23/2021 with complaints of weakness, diarrhea and coffee ground emesis. ED Evaluations revealing severe pancytopenia requiring transfusion. She did receive moderna COVID vaccine 8/7. She was admitted per CCMS to the ICU. Hematology consulted. Admit diagnosis of upper GI bleed and Pancytopenia. Course of illness: bone marrow biopsy shows aplasia, but with no evidence of leukemia or lymphoma. Started treatment course with transfusions which provided minimal/no benefit. Patient appears to be refractory to platelet infusions at this point. Procrit and Zarxio added for bone marrow stimulation but no improvement seen. Steroids also have shown no significant improvement in her pancytopenia. Dr. did mention giving her extra time to try to recover using the existing treatments in hopes of avoiding this, but hasnt seen any hopeful signs.  Dr. hasnt been able to find another possible cause and has been in contact with Moderna about her case. I believe that records are about to be released for Moderna to review.
Age: 72.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Platelet count decreased, White blood cell count decreased
Clinical narrative: 72-year-old female with a known medical history of DM, GERD, hypercholesterolemia, panic disorder, and daily ETOH use (2 large glasses of whiskey every night, last drink 8/21) presented 8/23/2021 with complaints of weakness, diarrhea and coffee ground emesis. ED Evaluations revealing severe pancytopenia requiring transfusion. She did receive moderna COVID vaccine 8/7. She was admitted per CCMS to the ICU. Hematology consulted. Admit diagnosis of upper GI bleed and Pancytopenia. Course of illness: bone marrow biopsy shows aplasia, but with no evidence of leukemia or lymphoma. Started treatment course with transfusions which provided minimal/no benefit. Patient appears to be refractory to platelet infusions at this point. Procrit and Zarxio added for bone marrow stimulation but no improvement seen. Steroids also have shown no significant improvement in her pancytopenia. Dr. did mention giving her extra time to try to recover using the existing treatments in hopes of avoiding this, but hasnt seen any hopeful signs.  Dr. hasnt been able to find another possible cause and has been in contact with Moderna about her case. I believe that records are about to be released for Moderna to review.
Age: 72.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Aplastic anaemia, Eosinophil count decreased, Eosinophil percentage, Haematocrit decreased, Haemoglobin decreased
Clinical narrative: 72-year-old female with a known medical history of DM, GERD, hypercholesterolemia, panic disorder, and daily ETOH use (2 large glasses of whiskey every night, last drink 8/21) presented 8/23/2021 with complaints of weakness, diarrhea and coffee ground emesis. ED Evaluations revealing severe pancytopenia requiring transfusion. She did receive moderna COVID vaccine 8/7. She was admitted per CCMS to the ICU. Hematology consulted. Admit diagnosis of upper GI bleed and Pancytopenia. Course of illness: bone marrow biopsy shows aplasia, but with no evidence of leukemia or lymphoma. Started treatment course with transfusions which provided minimal/no benefit. Patient appears to be refractory to platelet infusions at this point. Procrit and Zarxio added for bone marrow stimulation but no improvement seen. Steroids also have shown no significant improvement in her pancytopenia. Dr. did mention giving her extra time to try to recover using the existing treatments in hopes of avoiding this, but hasnt seen any hopeful signs.  Dr. hasnt been able to find another possible cause and has been in contact with Moderna about her case. I believe that records are about to be released for Moderna to review.
Age: 72.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Lymphocyte count, Lymphocyte percentage increased, Mean cell haemoglobin concentration decreased, Mean cell volume normal, Mean platelet volume increased
Clinical narrative: 72-year-old female with a known medical history of DM, GERD, hypercholesterolemia, panic disorder, and daily ETOH use (2 large glasses of whiskey every night, last drink 8/21) presented 8/23/2021 with complaints of weakness, diarrhea and coffee ground emesis. ED Evaluations revealing severe pancytopenia requiring transfusion. She did receive moderna COVID vaccine 8/7. She was admitted per CCMS to the ICU. Hematology consulted. Admit diagnosis of upper GI bleed and Pancytopenia. Course of illness: bone marrow biopsy shows aplasia, but with no evidence of leukemia or lymphoma. Started treatment course with transfusions which provided minimal/no benefit. Patient appears to be refractory to platelet infusions at this point. Procrit and Zarxio added for bone marrow stimulation but no improvement seen. Steroids also have shown no significant improvement in her pancytopenia. Dr. did mention giving her extra time to try to recover using the existing treatments in hopes of avoiding this, but hasnt seen any hopeful signs.  Dr. hasnt been able to find another possible cause and has been in contact with Moderna about her case. I believe that records are about to be released for Moderna to review.
Age: 72.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Monocyte count decreased, Monocyte percentage decreased, Platelet count decreased, Red blood cell count decreased, Red blood cell nucleated morphology
Clinical narrative: 72-year-old female with a known medical history of DM, GERD, hypercholesterolemia, panic disorder, and daily ETOH use (2 large glasses of whiskey every night, last drink 8/21) presented 8/23/2021 with complaints of weakness, diarrhea and coffee ground emesis. ED Evaluations revealing severe pancytopenia requiring transfusion. She did receive moderna COVID vaccine 8/7. She was admitted per CCMS to the ICU. Hematology consulted. Admit diagnosis of upper GI bleed and Pancytopenia. Course of illness: bone marrow biopsy shows aplasia, but with no evidence of leukemia or lymphoma. Started treatment course with transfusions which provided minimal/no benefit. Patient appears to be refractory to platelet infusions at this point. Procrit and Zarxio added for bone marrow stimulation but no improvement seen. Steroids also have shown no significant improvement in her pancytopenia. Dr. did mention giving her extra time to try to recover using the existing treatments in hopes of avoiding this, but hasnt seen any hopeful signs.  Dr. hasnt been able to find another possible cause and has been in contact with Moderna about her case. I believe that records are about to be released for Moderna to review.
Age: 72.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Red cell distribution width increased, White blood cell count decreased
Clinical narrative: 72-year-old female with a known medical history of DM, GERD, hypercholesterolemia, panic disorder, and daily ETOH use (2 large glasses of whiskey every night, last drink 8/21) presented 8/23/2021 with complaints of weakness, diarrhea and coffee ground emesis. ED Evaluations revealing severe pancytopenia requiring transfusion. She did receive moderna COVID vaccine 8/7. She was admitted per CCMS to the ICU. Hematology consulted. Admit diagnosis of upper GI bleed and Pancytopenia. Course of illness: bone marrow biopsy shows aplasia, but with no evidence of leukemia or lymphoma. Started treatment course with transfusions which provided minimal/no benefit. Patient appears to be refractory to platelet infusions at this point. Procrit and Zarxio added for bone marrow stimulation but no improvement seen. Steroids also have shown no significant improvement in her pancytopenia. Dr. did mention giving her extra time to try to recover using the existing treatments in hopes of avoiding this, but hasnt seen any hopeful signs.  Dr. hasnt been able to find another possible cause and has been in contact with Moderna about her case. I believe that records are about to be released for Moderna to review.
Age: 72.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Aplasia, Asthenia, Biopsy bone marrow abnormal, Diarrhoea, Full blood count abnormal
Clinical narrative: 72-year-old female with a known medical history of DM, GERD, hypercholesterolemia, panic disorder, and daily ETOH use (2 large glasses of whiskey every night, last drink 8/21) presented 8/23/2021 with complaints of weakness, diarrhea and coffee ground emesis. ED Evaluations revealing severe pancytopenia requiring transfusion. She did receive moderna COVID vaccine 8/7. She was admitted per CCMS to the ICU. Hematology consulted. Admit diagnosis of upper GI bleed and Pancytopenia. Course of illness: bone marrow biopsy shows aplasia, but with no evidence of leukemia or lymphoma. Started treatment course with transfusions which provided minimal/no benefit. Patient appears to be refractory to platelet infusions at this point. Procrit and Zarxio added for bone marrow stimulation but no improvement seen. Steroids also have shown no significant improvement in her pancytopenia. Dr. did mention giving her extra time to try to recover using the existing treatments in hopes of avoiding this, but hasnt seen any hopeful signs.  Dr. hasnt been able to find another possible cause and has been in contact with Moderna about her case. I believe that records are about to be released for Moderna to review.
Age: 72.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Haematemesis, Haematocrit decreased, Haemoglobin decreased, Intensive care, Pancytopenia
Clinical narrative: 72-year-old female with a known medical history of DM, GERD, hypercholesterolemia, panic disorder, and daily ETOH use (2 large glasses of whiskey every night, last drink 8/21) presented 8/23/2021 with complaints of weakness, diarrhea and coffee ground emesis. ED Evaluations revealing severe pancytopenia requiring transfusion. She did receive moderna COVID vaccine 8/7. She was admitted per CCMS to the ICU. Hematology consulted. Admit diagnosis of upper GI bleed and Pancytopenia. Course of illness: bone marrow biopsy shows aplasia, but with no evidence of leukemia or lymphoma. Started treatment course with transfusions which provided minimal/no benefit. Patient appears to be refractory to platelet infusions at this point. Procrit and Zarxio added for bone marrow stimulation but no improvement seen. Steroids also have shown no significant improvement in her pancytopenia. Dr. did mention giving her extra time to try to recover using the existing treatments in hopes of avoiding this, but hasnt seen any hopeful signs.  Dr. hasnt been able to find another possible cause and has been in contact with Moderna about her case. I believe that records are about to be released for Moderna to review.
Age: 72.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Red blood cell count decreased, Transfusion, Upper gastrointestinal haemorrhage, White blood cell count decreased
Clinical narrative: 72-year-old female with a known medical history of DM, GERD, hypercholesterolemia, panic disorder, and daily ETOH use (2 large glasses of whiskey every night, last drink 8/21) presented 8/23/2021 with complaints of weakness, diarrhea and coffee ground emesis. ED Evaluations revealing severe pancytopenia requiring transfusion. She did receive moderna COVID vaccine 8/7. She was admitted per CCMS to the ICU. Hematology consulted. Admit diagnosis of upper GI bleed and Pancytopenia. Course of illness: bone marrow biopsy shows aplasia, but with no evidence of leukemia or lymphoma. Started treatment course with transfusions which provided minimal/no benefit. Patient appears to be refractory to platelet infusions at this point. Procrit and Zarxio added for bone marrow stimulation but no improvement seen. Steroids also have shown no significant improvement in her pancytopenia. Dr. did mention giving her extra time to try to recover using the existing treatments in hopes of avoiding this, but hasnt seen any hopeful signs.  Dr. hasnt been able to find another possible cause and has been in contact with Moderna about her case. I believe that records are about to be released for Moderna to review.
Age: 68.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Acute respiratory failure, Bilevel positive airway pressure, Computerised tomogram thorax, Computerised tomogram thorax abnormal, Lung opacity
Clinical narrative: ACUTE RESPIRATORY FAILURE WITH HYPOXIA, COVID POSITIVE, PNEUMONIA DUE TO COVID, HX OF HTN AND DM2
Age: 68.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Oxygen saturation decreased, Pneumonia viral
Clinical narrative: ACUTE RESPIRATORY FAILURE WITH HYPOXIA, COVID POSITIVE, PNEUMONIA DUE TO COVID, HX OF HTN AND DM2
Age: 68.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Acute respiratory failure, COVID-19, COVID-19 pneumonia, SARS-CoV-2 test positive
Clinical narrative: ACUTE RESPIRATORY FAILURE WITH HYPOXIA, COVID POSITIVE, PNEUMONIA DUE TO COVID, HX OF HTN AND DM2
Age: 40.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chest pain, Pain in extremity, Taste disorder, Throat irritation
Clinical narrative: Immediately started tasting saline. Ten minutes later my chest felt weird and started hurting like a burning sensation. I called my doctor and was told to go to the er. I went to the ER and waited over 4 hours and eventually left due to them being under staffed.
Age: 40.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood test, Chest X-ray, Chest pain, Electrocardiogram, Feeling abnormal
Clinical narrative: Immediately started tasting saline. Ten minutes later my chest felt weird and started hurting like a burning sensation. I called my doctor and was told to go to the er. I went to the ER and waited over 4 hours and eventually left due to them being under staffed.
Age: 40.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Immediate post-injection reaction, Taste disorder
Clinical narrative: Immediately started tasting saline. Ten minutes later my chest felt weird and started hurting like a burning sensation. I called my doctor and was told to go to the er. I went to the ER and waited over 4 hours and eventually left due to them being under staffed.
Age: 45.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Allergy test, Antimitochondrial antibody, Autoimmune disorder, Biopsy, Crying
Clinical narrative: had rashes after 2nd dose in less than 2 months interval
Age: 45.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dermatitis, Herpes zoster, Insomnia, Investigation, Pruritus
Clinical narrative: had rashes after 2nd dose in less than 2 months interval
Age: 45.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Rash, Urticaria
Clinical narrative: had rashes after 2nd dose in less than 2 months interval
Age: 45.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Alanine aminotransferase, Antinuclear antibody, Antiphospholipid antibodies, Beta-2 glycoprotein antibody, Blood creatine phosphokinase
Clinical narrative: had rashes after 2nd dose in less than 2 months interval
Age: 45.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood creatinine, Blood glucose, Blood immunoglobulin A, Blood immunoglobulin G, Blood immunoglobulin M
Clinical narrative: had rashes after 2nd dose in less than 2 months interval
Age: 45.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood potassium, Blood thyroid stimulating hormone, Cardiolipin antibody, Complement factor C3, Complement factor C4
Clinical narrative: had rashes after 2nd dose in less than 2 months interval
Age: 45.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Differential white blood cell count, Electrophoresis protein, Full blood count, Glomerular filtration rate, Glycosylated haemoglobin
Clinical narrative: had rashes after 2nd dose in less than 2 months interval
Age: 45.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Inappropriate schedule of product administration, Lipids, Rash, Rheumatoid factor
Clinical narrative: had rashes after 2nd dose in less than 2 months interval
Age: 37.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Interchange of vaccine products
Clinical narrative: Patient received J+J vaccine on 3/9/2021 and then received Pfizer vaccine on 8/8/2021 as documented on this report.
Age: 37.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Extra dose administered, Interchange of vaccine products
Clinical narrative: Patient received J+J vaccine on 3/9/2021 and then received Pfizer vaccine on 8/8/2021 as documented on this report.
Age: 71.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: None stated.
Age: 71.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Unevaluable event
Clinical narrative: None stated.
Age: 24.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Blood test, Chest pain, Condition aggravated, Echocardiogram, Electrocardiogram ambulatory
Clinical narrative: After second dose of vaccine within 48-72 hours pt's palpitations increased significantly. Member had to be placed on betablocker to help control symptoms.
Age: 24.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Fatigue, Palpitations, Ventricular extrasystoles
Clinical narrative: After second dose of vaccine within 48-72 hours pt's palpitations increased significantly. Member had to be placed on betablocker to help control symptoms.
Age: 24.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Palpitations
Clinical narrative: After second dose of vaccine within 48-72 hours pt's palpitations increased significantly. Member had to be placed on betablocker to help control symptoms.
Age: 16.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Blood creatine phosphokinase MB increased, Blood creatine phosphokinase increased, C-reactive protein increased, Chest X-ray normal, Chest pain
Clinical narrative: Adverse reaction later identified as Acute Myopericarditis.  Symptoms: severe left arm, jaw, chest, and head pain/numbness. Very cold hands/feet.  Shortness of breath, difficulty breathing especially sitting up and/or leaning forward. Outcome of event:  hospitalization, moved to Intensive Care Unit.
Age: 16.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Dyspnoea, Echocardiogram normal, Electrocardiogram ST segment depression, Electrocardiogram ST segment elevation, Headache
Clinical narrative: Adverse reaction later identified as Acute Myopericarditis.  Symptoms: severe left arm, jaw, chest, and head pain/numbness. Very cold hands/feet.  Shortness of breath, difficulty breathing especially sitting up and/or leaning forward. Outcome of event:  hospitalization, moved to Intensive Care Unit.
Age: 16.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Hypoaesthesia, Myocarditis, Nausea, Pain in jaw, Troponin increased
Clinical narrative: Adverse reaction later identified as Acute Myopericarditis.  Symptoms: severe left arm, jaw, chest, and head pain/numbness. Very cold hands/feet.  Shortness of breath, difficulty breathing especially sitting up and/or leaning forward. Outcome of event:  hospitalization, moved to Intensive Care Unit.
Age: 16.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Pericarditis
Clinical narrative: Adverse reaction later identified as Acute Myopericarditis.  Symptoms: severe left arm, jaw, chest, and head pain/numbness. Very cold hands/feet.  Shortness of breath, difficulty breathing especially sitting up and/or leaning forward. Outcome of event:  hospitalization, moved to Intensive Care Unit.
Age: 16.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Chest pain, Dyspnoea, Headache, Hypoaesthesia, Intensive care
Clinical narrative: Adverse reaction later identified as Acute Myopericarditis.  Symptoms: severe left arm, jaw, chest, and head pain/numbness. Very cold hands/feet.  Shortness of breath, difficulty breathing especially sitting up and/or leaning forward. Outcome of event:  hospitalization, moved to Intensive Care Unit.
Age: 16.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Myocarditis, Pain in extremity, Pain in jaw, Peripheral coldness
Clinical narrative: Adverse reaction later identified as Acute Myopericarditis.  Symptoms: severe left arm, jaw, chest, and head pain/numbness. Very cold hands/feet.  Shortness of breath, difficulty breathing especially sitting up and/or leaning forward. Outcome of event:  hospitalization, moved to Intensive Care Unit.
Age: 26.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pruritus
Clinical narrative: Within 5 minutes of receiving the vaccine and being asked to wait by the pharmacy I began getting hives on my eyebrows, back of arms by my armpits, chest, jawline and neck. Within 10 minutes I had a full blown rash, hives, sore/swollen tongue, itchy/watery eyes and throat tightening. I was given 50mg of diphenhydramine and was monitored by a pharmacist for 50 minutes post vaccine. I was told to call 911 if chest pain/shortness of breath occurred. I monitored my symptoms on my own after 1hr of being monitored by the pharmacist. The allergic reaction continued for 48hrs. Chest tightness occurred 9-10hrs after injection but was reduced with another 50mg dose of diphenhydramine. The injection site became swollen, red, irritated and incredibly itchy 7 days after the injection.
Age: 26.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chest discomfort, Eye pruritus, Glossodynia, Injection site erythema, Injection site irritation
Clinical narrative: Within 5 minutes of receiving the vaccine and being asked to wait by the pharmacy I began getting hives on my eyebrows, back of arms by my armpits, chest, jawline and neck. Within 10 minutes I had a full blown rash, hives, sore/swollen tongue, itchy/watery eyes and throat tightening. I was given 50mg of diphenhydramine and was monitored by a pharmacist for 50 minutes post vaccine. I was told to call 911 if chest pain/shortness of breath occurred. I monitored my symptoms on my own after 1hr of being monitored by the pharmacist. The allergic reaction continued for 48hrs. Chest tightness occurred 9-10hrs after injection but was reduced with another 50mg dose of diphenhydramine. The injection site became swollen, red, irritated and incredibly itchy 7 days after the injection.
Age: 26.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Injection site pruritus, Injection site swelling, Lacrimation increased, Rash, Swollen tongue
Clinical narrative: Within 5 minutes of receiving the vaccine and being asked to wait by the pharmacy I began getting hives on my eyebrows, back of arms by my armpits, chest, jawline and neck. Within 10 minutes I had a full blown rash, hives, sore/swollen tongue, itchy/watery eyes and throat tightening. I was given 50mg of diphenhydramine and was monitored by a pharmacist for 50 minutes post vaccine. I was told to call 911 if chest pain/shortness of breath occurred. I monitored my symptoms on my own after 1hr of being monitored by the pharmacist. The allergic reaction continued for 48hrs. Chest tightness occurred 9-10hrs after injection but was reduced with another 50mg dose of diphenhydramine. The injection site became swollen, red, irritated and incredibly itchy 7 days after the injection.
Age: 26.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Throat tightness, Urticaria
Clinical narrative: Within 5 minutes of receiving the vaccine and being asked to wait by the pharmacy I began getting hives on my eyebrows, back of arms by my armpits, chest, jawline and neck. Within 10 minutes I had a full blown rash, hives, sore/swollen tongue, itchy/watery eyes and throat tightening. I was given 50mg of diphenhydramine and was monitored by a pharmacist for 50 minutes post vaccine. I was told to call 911 if chest pain/shortness of breath occurred. I monitored my symptoms on my own after 1hr of being monitored by the pharmacist. The allergic reaction continued for 48hrs. Chest tightness occurred 9-10hrs after injection but was reduced with another 50mg dose of diphenhydramine. The injection site became swollen, red, irritated and incredibly itchy 7 days after the injection.
Age: 31.0
Sex: U
Vaccine: COVID19, COVID19
Symptoms: Toothache
Clinical narrative: covid test result Positive; covid test result Positive; This is a spontaneous report from a contactable other HCP (patient).   A 31-years-old patient of an unspecified gender received bnt162b2 (BNT162B2), dose 2 via an unspecified route of administration on 20Jan2021 10:00 (Batch/Lot Number: Ek9231) as single dose, and first dose via an unspecified route of administration on 30Dec2020 08:00 (Batch/Lot Number: EH9899) as single dose, both in left arm and for covid-19 immunisation (age at vaccination 31 year old).  The patient medical history was not reported. patient had no known allergies. Concomitant medication(s) included amfetamine aspartate/amfetamine sulfate/dexamfetamine saccharate/dexamfetamine sulfate (ADDERALL) taken for an unspecified indication, start and stop date were not reported (in two weeks from  vaccination).  On 23Apr2021, the patient experienced nasal swab COVID test (PCR) positive, Vaccination failure. Outcome of events was unknown.; Sender's Comments: The contributory role of the suspect product to the reported drug ineffective cannot be excluded as the efficacy of a drug varies individually and may be affected by different factors including drug potency.
Age: 31.0
Sex: U
Vaccine: COVID19, COVID19
Symptoms: COVID-19, SARS-CoV-2 antibody test, Vaccination failure
Clinical narrative: covid test result Positive; covid test result Positive; This is a spontaneous report from a contactable other HCP (patient).   A 31-years-old patient of an unspecified gender received bnt162b2 (BNT162B2), dose 2 via an unspecified route of administration on 20Jan2021 10:00 (Batch/Lot Number: Ek9231) as single dose, and first dose via an unspecified route of administration on 30Dec2020 08:00 (Batch/Lot Number: EH9899) as single dose, both in left arm and for covid-19 immunisation (age at vaccination 31 year old).  The patient medical history was not reported. patient had no known allergies. Concomitant medication(s) included amfetamine aspartate/amfetamine sulfate/dexamfetamine saccharate/dexamfetamine sulfate (ADDERALL) taken for an unspecified indication, start and stop date were not reported (in two weeks from  vaccination).  On 23Apr2021, the patient experienced nasal swab COVID test (PCR) positive, Vaccination failure. Outcome of events was unknown.; Sender's Comments: The contributory role of the suspect product to the reported drug ineffective cannot be excluded as the efficacy of a drug varies individually and may be affected by different factors including drug potency.
Age: 39.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pruritus, Urticaria
Clinical narrative: Rash over most of my body, developed about 1 hour after vaccine injection. Benadryl was given by pharmacist, and continued for 36 hours at 50mg every 6 hours. After approximately 36 hours, rash was mostly gone.
Age: 39.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Rash
Clinical narrative: Rash over most of my body, developed about 1 hour after vaccine injection. Benadryl was given by pharmacist, and continued for 36 hours at 50mg every 6 hours. After approximately 36 hours, rash was mostly gone.
Age: 64.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Cerebrovascular accident, Computerised tomogram, Decreased appetite, Electrocardiogram, Hemiplegia
Clinical narrative: HAD 1 STROKE 2-3 DAYS AFTER VACCINE, 7 DAYS LATER ANOTHER STROKE. CANNOT EAT FOOD OR DRINK BECAUSE THE TASTE IS TOO BAD; CAN ONLY DRINK BOOST.
Age: 64.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Speech disorder
Clinical narrative: HAD 1 STROKE 2-3 DAYS AFTER VACCINE, 7 DAYS LATER ANOTHER STROKE. CANNOT EAT FOOD OR DRINK BECAUSE THE TASTE IS TOO BAD; CAN ONLY DRINK BOOST.
Age: 64.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Cerebrovascular accident, Decreased appetite, Feeding disorder, Fluid intake reduced, Laboratory test
Clinical narrative: HAD 1 STROKE 2-3 DAYS AFTER VACCINE, 7 DAYS LATER ANOTHER STROKE. CANNOT EAT FOOD OR DRINK BECAUSE THE TASTE IS TOO BAD; CAN ONLY DRINK BOOST.
Age: 64.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Pain, Taste disorder
Clinical narrative: HAD 1 STROKE 2-3 DAYS AFTER VACCINE, 7 DAYS LATER ANOTHER STROKE. CANNOT EAT FOOD OR DRINK BECAUSE THE TASTE IS TOO BAD; CAN ONLY DRINK BOOST.
Age: 64.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Cerebrovascular accident, Speech disorder
Clinical narrative: HAD 1 STROKE 2-3 DAYS AFTER VACCINE, 7 DAYS LATER ANOTHER STROKE. CANNOT EAT FOOD OR DRINK BECAUSE THE TASTE IS TOO BAD; CAN ONLY DRINK BOOST.
Age: 64.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Asthenia, Cerebrovascular accident, Eating disorder, Loss of personal independence in daily activities, Malaise
Clinical narrative: HAD 1 STROKE 2-3 DAYS AFTER VACCINE, 7 DAYS LATER ANOTHER STROKE. CANNOT EAT FOOD OR DRINK BECAUSE THE TASTE IS TOO BAD; CAN ONLY DRINK BOOST.
Age: 64.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Mouth injury, Pain in extremity, Speech disorder
Clinical narrative: HAD 1 STROKE 2-3 DAYS AFTER VACCINE, 7 DAYS LATER ANOTHER STROKE. CANNOT EAT FOOD OR DRINK BECAUSE THE TASTE IS TOO BAD; CAN ONLY DRINK BOOST.
Age: 73.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Angiogram, Anticoagulant therapy, Catheterisation cardiac abnormal, Chest pain, Computerised tomogram thorax normal
Clinical narrative: right chest wall pain -- started 2days after 2nd shot -----persisted and in ER on 08/31/2021, dx of non-st myocardial infarction .  there had been no change in symptoms.  echocardiogram OK and symptoms have improved
Age: 73.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Condition aggravated, Coronary artery disease, Cough, Diaphragmatic disorder, Electrocardiogram QT prolonged
Clinical narrative: right chest wall pain -- started 2days after 2nd shot -----persisted and in ER on 08/31/2021, dx of non-st myocardial infarction .  there had been no change in symptoms.  echocardiogram OK and symptoms have improved
Age: 73.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Fatigue, Musculoskeletal chest pain, Peripheral vein stenosis, Pulmonary mass, Swelling
Clinical narrative: right chest wall pain -- started 2days after 2nd shot -----persisted and in ER on 08/31/2021, dx of non-st myocardial infarction .  there had been no change in symptoms.  echocardiogram OK and symptoms have improved
Age: 73.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Troponin increased
Clinical narrative: right chest wall pain -- started 2days after 2nd shot -----persisted and in ER on 08/31/2021, dx of non-st myocardial infarction .  there had been no change in symptoms.  echocardiogram OK and symptoms have improved
Age: 73.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Acute myocardial infarction, Arteriogram coronary normal, Echocardiogram normal, Ejection fraction normal, Musculoskeletal chest pain
Clinical narrative: right chest wall pain -- started 2days after 2nd shot -----persisted and in ER on 08/31/2021, dx of non-st myocardial infarction .  there had been no change in symptoms.  echocardiogram OK and symptoms have improved
Age: 73.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Troponin
Clinical narrative: right chest wall pain -- started 2days after 2nd shot -----persisted and in ER on 08/31/2021, dx of non-st myocardial infarction .  there had been no change in symptoms.  echocardiogram OK and symptoms have improved
Age: 53.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Pruritus
Clinical narrative: 9/7/2021 Itching all over 13 minutes after vaccine. Benadryl 50mg given on site. Oro-pharyngeal swelling an hour and a half later.  Night sweats 9/7 and 9/8. 9/9/2021 0600am Breathing difficulty/ tightness. Dulera was taken at 0545am. Proventil taken at 0600 with no change. Proventil taken again at 0603am with no change.  Drove directly to ER.
Age: 53.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Chest X-ray normal, Chest discomfort, Dyspnoea, Laboratory test, Night sweats
Clinical narrative: 9/7/2021 Itching all over 13 minutes after vaccine. Benadryl 50mg given on site. Oro-pharyngeal swelling an hour and a half later.  Night sweats 9/7 and 9/8. 9/9/2021 0600am Breathing difficulty/ tightness. Dulera was taken at 0545am. Proventil taken at 0600 with no change. Proventil taken again at 0603am with no change.  Drove directly to ER.
Age: 53.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Oropharyngeal swelling, Pruritus
Clinical narrative: 9/7/2021 Itching all over 13 minutes after vaccine. Benadryl 50mg given on site. Oro-pharyngeal swelling an hour and a half later.  Night sweats 9/7 and 9/8. 9/9/2021 0600am Breathing difficulty/ tightness. Dulera was taken at 0545am. Proventil taken at 0600 with no change. Proventil taken again at 0603am with no change.  Drove directly to ER.
Age: 17.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Electrocardiogram, Fatigue
Clinical narrative: THE VACCINE WAS GIVEN TO THIS PATIENT AT 8:41 AM. THE PATIENT  FELT LIGHT HEADED AND SICK A FEW MINUTES FOLLOWING THE VACCINE. I WALKED IN THE ROOM TO CHECK ON HIM AND I ASKED "YOU FEELING ALRIGHT?" HE REPLIED "NO, I DONT FEEL SO WELL." I ASKED "ARE YOU FEELING SICK?" HE REPLIED "A LITTLE." I WENT AND TOLD THE NP ON SHIFT. THE PATIENT WAS PALE AND HIS BODY FELT WEAK. VITAL SIGNS WERE OBTAINED AT THAT TIME AND REVEALED NOTHING ABNORMAL. WE THEN PERFORMED AN EKG AND THE PATIENT WAS SINUS BRADY. AFTER A FEW MOMENTS A HEART RATE WAS CHECKED AGAIN AND HE WAS WITHIN THE NORMAL RANGE AT 68. THE PATIENT REGAINED FULL MOTOR SKILLS AND WAS  DISCHARGED. WE BELEIVE THE PATIENT HAD A VASOVAGAL RESPONSE TO BEING STUCK BY THE NEEDLE CAUSING THE REACTION HE HAD.  NO FURTHER ELEMENTS HAVE BEEN REPORTED TO THE STAFF FOLLOWING THIS EVENT.
Age: 17.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Asthenia, COVID-19, Dizziness, Electrocardiogram, Malaise
Clinical narrative: THE VACCINE WAS GIVEN TO THIS PATIENT AT 8:41 AM. THE PATIENT  FELT LIGHT HEADED AND SICK A FEW MINUTES FOLLOWING THE VACCINE. I WALKED IN THE ROOM TO CHECK ON HIM AND I ASKED "YOU FEELING ALRIGHT?" HE REPLIED "NO, I DONT FEEL SO WELL." I ASKED "ARE YOU FEELING SICK?" HE REPLIED "A LITTLE." I WENT AND TOLD THE NP ON SHIFT. THE PATIENT WAS PALE AND HIS BODY FELT WEAK. VITAL SIGNS WERE OBTAINED AT THAT TIME AND REVEALED NOTHING ABNORMAL. WE THEN PERFORMED AN EKG AND THE PATIENT WAS SINUS BRADY. AFTER A FEW MOMENTS A HEART RATE WAS CHECKED AGAIN AND HE WAS WITHIN THE NORMAL RANGE AT 68. THE PATIENT REGAINED FULL MOTOR SKILLS AND WAS  DISCHARGED. WE BELEIVE THE PATIENT HAD A VASOVAGAL RESPONSE TO BEING STUCK BY THE NEEDLE CAUSING THE REACTION HE HAD.  NO FURTHER ELEMENTS HAVE BEEN REPORTED TO THE STAFF FOLLOWING THIS EVENT.
Age: 17.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Motor dysfunction, Pallor, Sinus bradycardia
Clinical narrative: THE VACCINE WAS GIVEN TO THIS PATIENT AT 8:41 AM. THE PATIENT  FELT LIGHT HEADED AND SICK A FEW MINUTES FOLLOWING THE VACCINE. I WALKED IN THE ROOM TO CHECK ON HIM AND I ASKED "YOU FEELING ALRIGHT?" HE REPLIED "NO, I DONT FEEL SO WELL." I ASKED "ARE YOU FEELING SICK?" HE REPLIED "A LITTLE." I WENT AND TOLD THE NP ON SHIFT. THE PATIENT WAS PALE AND HIS BODY FELT WEAK. VITAL SIGNS WERE OBTAINED AT THAT TIME AND REVEALED NOTHING ABNORMAL. WE THEN PERFORMED AN EKG AND THE PATIENT WAS SINUS BRADY. AFTER A FEW MOMENTS A HEART RATE WAS CHECKED AGAIN AND HE WAS WITHIN THE NORMAL RANGE AT 68. THE PATIENT REGAINED FULL MOTOR SKILLS AND WAS  DISCHARGED. WE BELEIVE THE PATIENT HAD A VASOVAGAL RESPONSE TO BEING STUCK BY THE NEEDLE CAUSING THE REACTION HE HAD.  NO FURTHER ELEMENTS HAVE BEEN REPORTED TO THE STAFF FOLLOWING THIS EVENT.
Age: 15.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chills, Pain in extremity, Pyrexia
Clinical narrative: Patient came to get the Pfizer vaccine, but was given the Moderna vaccine instead.
Age: 15.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Interchange of vaccine products
Clinical narrative: Patient came to get the Pfizer vaccine, but was given the Moderna vaccine instead.
Age: 37.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19
Symptoms: Abdominal pain, Activated partial thromboplastin time shortened, Antibody test positive, Anticoagulant therapy, Blood fibrinogen decreased
Clinical narrative: [Johnson & Johnson Vaccine] use for COVID-19 under Emergency Use Authorization (EUA): The patient developed VITT (vaccine- induced thrombotic thrombocytopenia) 9 days following administration of the Johnson & Johnson vaccine. The patient demised from catastrophic intracranial hemorrhage, infarction and clot formation. The diagnosis was clear based on the clinical presentation, laboratory and radiological findings. The patient had no comorbidity and was not receiving concurrent medication.
Age: 37.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19
Symptoms: Blood lactate dehydrogenase normal, Brain death, Cerebral haemorrhage, Computerised tomogram head abnormal, Craniotomy
Clinical narrative: [Johnson & Johnson Vaccine] use for COVID-19 under Emergency Use Authorization (EUA): The patient developed VITT (vaccine- induced thrombotic thrombocytopenia) 9 days following administration of the Johnson & Johnson vaccine. The patient demised from catastrophic intracranial hemorrhage, infarction and clot formation. The diagnosis was clear based on the clinical presentation, laboratory and radiological findings. The patient had no comorbidity and was not receiving concurrent medication.
Age: 37.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19
Symptoms: Death, Fibrin D dimer increased, Haemoglobin normal, Haemostasis, Haptoglobin normal
Clinical narrative: [Johnson & Johnson Vaccine] use for COVID-19 under Emergency Use Authorization (EUA): The patient developed VITT (vaccine- induced thrombotic thrombocytopenia) 9 days following administration of the Johnson & Johnson vaccine. The patient demised from catastrophic intracranial hemorrhage, infarction and clot formation. The diagnosis was clear based on the clinical presentation, laboratory and radiological findings. The patient had no comorbidity and was not receiving concurrent medication.
Age: 37.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19
Symptoms: Headache, Heparin-induced thrombocytopenia test positive, Immunoglobulin therapy, Infarction, International normalised ratio increased
Clinical narrative: [Johnson & Johnson Vaccine] use for COVID-19 under Emergency Use Authorization (EUA): The patient developed VITT (vaccine- induced thrombotic thrombocytopenia) 9 days following administration of the Johnson & Johnson vaccine. The patient demised from catastrophic intracranial hemorrhage, infarction and clot formation. The diagnosis was clear based on the clinical presentation, laboratory and radiological findings. The patient had no comorbidity and was not receiving concurrent medication.
Age: 37.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19
Symptoms: Intracranial pressure increased, Neurological decompensation, Ovarian vein thrombosis, Platelet count decreased, Prothrombin time prolonged
Clinical narrative: [Johnson & Johnson Vaccine] use for COVID-19 under Emergency Use Authorization (EUA): The patient developed VITT (vaccine- induced thrombotic thrombocytopenia) 9 days following administration of the Johnson & Johnson vaccine. The patient demised from catastrophic intracranial hemorrhage, infarction and clot formation. The diagnosis was clear based on the clinical presentation, laboratory and radiological findings. The patient had no comorbidity and was not receiving concurrent medication.
Age: 37.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19
Symptoms: Renal vein thrombosis, Thrombocytopenia, Transfusion, Ventricular drainage, White blood cell count increased
Clinical narrative: [Johnson & Johnson Vaccine] use for COVID-19 under Emergency Use Authorization (EUA): The patient developed VITT (vaccine- induced thrombotic thrombocytopenia) 9 days following administration of the Johnson & Johnson vaccine. The patient demised from catastrophic intracranial hemorrhage, infarction and clot formation. The diagnosis was clear based on the clinical presentation, laboratory and radiological findings. The patient had no comorbidity and was not receiving concurrent medication.
Age: 37.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19
Symptoms: Withdrawal of life support
Clinical narrative: [Johnson & Johnson Vaccine] use for COVID-19 under Emergency Use Authorization (EUA): The patient developed VITT (vaccine- induced thrombotic thrombocytopenia) 9 days following administration of the Johnson & Johnson vaccine. The patient demised from catastrophic intracranial hemorrhage, infarction and clot formation. The diagnosis was clear based on the clinical presentation, laboratory and radiological findings. The patient had no comorbidity and was not receiving concurrent medication.
Age: 37.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19
Symptoms: Anticoagulant therapy, Brain death, Cerebral haemorrhage, Cerebral mass effect, Death
Clinical narrative: [Johnson & Johnson Vaccine] use for COVID-19 under Emergency Use Authorization (EUA): The patient developed VITT (vaccine- induced thrombotic thrombocytopenia) 9 days following administration of the Johnson & Johnson vaccine. The patient demised from catastrophic intracranial hemorrhage, infarction and clot formation. The diagnosis was clear based on the clinical presentation, laboratory and radiological findings. The patient had no comorbidity and was not receiving concurrent medication.
Age: 37.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19
Symptoms: Decompressive craniectomy, Immunoglobulin therapy, Loss of consciousness, Thrombosis with thrombocytopenia syndrome, Unresponsive to stimuli
Clinical narrative: [Johnson & Johnson Vaccine] use for COVID-19 under Emergency Use Authorization (EUA): The patient developed VITT (vaccine- induced thrombotic thrombocytopenia) 9 days following administration of the Johnson & Johnson vaccine. The patient demised from catastrophic intracranial hemorrhage, infarction and clot formation. The diagnosis was clear based on the clinical presentation, laboratory and radiological findings. The patient had no comorbidity and was not receiving concurrent medication.
Age: 37.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19
Symptoms: Ventricular drainage
Clinical narrative: [Johnson & Johnson Vaccine] use for COVID-19 under Emergency Use Authorization (EUA): The patient developed VITT (vaccine- induced thrombotic thrombocytopenia) 9 days following administration of the Johnson & Johnson vaccine. The patient demised from catastrophic intracranial hemorrhage, infarction and clot formation. The diagnosis was clear based on the clinical presentation, laboratory and radiological findings. The patient had no comorbidity and was not receiving concurrent medication.
Age: 37.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19
Symptoms: Death
Clinical narrative: [Johnson & Johnson Vaccine] use for COVID-19 under Emergency Use Authorization (EUA): The patient developed VITT (vaccine- induced thrombotic thrombocytopenia) 9 days following administration of the Johnson & Johnson vaccine. The patient demised from catastrophic intracranial hemorrhage, infarction and clot formation. The diagnosis was clear based on the clinical presentation, laboratory and radiological findings. The patient had no comorbidity and was not receiving concurrent medication.